Water and wastewater treatment company, Fluence Corporation (ASX:FLC) has been awarded a contract to deliver an Aspiral smart packaged plant solution in China.
The new contract is for a large wastewater plant in the Guizhou province.
It’s the third contract secured by Fluence’s Chinese partner, Jinzi Environment Company.
Fluence says Jinzi recognises the significant advantages of Aspiral for the treatment of wastewater in China.
Aspiral is a range of wastewater treatment solutions, based on its innovative Membrane Aerated Biofilm Reactor (MABR) technology.
Shares in Fluence Corporation (ASX:FLC) are trading 3.85 per cent higher to 41 cents.